(ALTUV) BIO UV - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0013345493
ALTUV: Water, Treatment, Devices, Disinfectant, UV, Systems, Purifiers
BIO-UV Group S.A. is a France-based company specializing in UV light-based water treatment and surface disinfection solutions. Since its inception in 2000, the company has developed a diverse portfolio of products tailored for residential, commercial, and industrial applications. Its offerings include systems for swimming pools, drinking water treatment, wastewater disinfection, and industrial process water management. BIO-UV Group also addresses niche markets such as aquaculture, maritime ballast water treatment, and surface disinfection in public and medical settings.
The companys product range includes OClear UV for drinking water, DELTA-UV for pools, and BIO-SEA for maritime applications. Additionally, BIO-UV Group provides solutions for specific industrial needs, such as RW systems for municipal wastewater and IBP systems for industrial processes. Its surface disinfection products, like BIO-SCAN LIGHT, cater to healthcare and public spaces. The company serves clients across Europe, Asia, the Middle East, and the Americas, with a strong focus on innovation and environmental sustainability.
Additional Sources for ALTUV Stock
ALTUV Stock Overview
| Market Cap in USD | 27m |
| Sector | Industrials |
| Industry | Pollution & Treatment Controls |
| GiC Sub-Industry | Environmental & Facilities Services |
| IPO / Inception |
ALTUV Stock Ratings
| Growth Rating | -82.9 |
| Fundamental | 41.8 |
| Dividend Rating | 1.0 |
| Rel. Strength | -32.1 |
| Analysts | - |
| Fair Price Momentum | 1.20 EUR |
| Fair Price DCF | 9.95 EUR |
ALTUV Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 26.4% |
ALTUV Growth Ratios
| Growth Correlation 3m | -92.1% |
| Growth Correlation 12m | -49.9% |
| Growth Correlation 5y | -95.4% |
| CAGR 5y | -23.53% |
| CAGR/Max DD 5y | -0.30 |
| Sharpe Ratio 12m | -0.45 |
| Alpha | -28.96 |
| Beta | -0.065 |
| Volatility | 36.69% |
| Current Volume | 9k |
| Average Volume 20d | 8.2k |
As of April 29, 2025, the stock is trading at EUR 1.64 with a total of 8,950 shares traded.
Over the past week, the price has changed by -0.74%, over one month by -15.31%, over three months by -22.28% and over the past year by -27.76%.
Partly, yes. Based on ValueRay Fundamental Analyses, BIO UV (PA:ALTUV) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 41.79 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALTUV as of April 2025 is 1.20. This means that ALTUV is currently overvalued and has a potential downside of -26.83%.
BIO UV has no consensus analysts rating.
According to ValueRays Forecast Model, ALTUV BIO UV will be worth about 1.3 in April 2026. The stock is currently trading at 1.64. This means that the stock has a potential downside of -20.73%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 3.6 | 119.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1.3 | -20.7% |